Investing Profile

Claire Brown

InvestorVC
Partner at Oxford Science Enterprises
oxfordscienceenterprises.com/...Oxford, United Kingdom
Photo of Claire Brown, Partner at Oxford Science Enterprises

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Sanofi Network
30 CONNECTIONS
University of Glasgow Network
20 CONNECTIONS
AstraZeneca Network
19 CONNECTIONS
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Scripta Therapeutics
SeedNov 2025$12M
$12M
Co-investors: Marianne Mertens (Apollo Health Ventures)
AlveoGene
SeedSep 2023
Rinri Therapeutics
SeedMay 2019$2M
$14M
Co-investors: Frank Kalkbrenner (Hotmail)
Pharmacology Dept, Principal Scientist UCBPresent
Principal Scientist, Pharmacology & Toxicology SanofiPresent
Director, Strategy, Business Development and Investment AstraZenecaPresent
Head of Investment Pioneer GroupPresent
Board Of Directors Rinri TherapeuticsPresent
Board Of Directors KinomicaPresent
Board of Directors NanoSyrinxPresent
Board Director Dark Blue TherapeuticsPresent
Board Director T-Cypher BioPresent
Board Observer OMass TherapeuticsPresent
Board Director Alethio TherapeuticsPresent
Board Director Orfonyx BioPresent
Board Observer Nucleome TherapeuticsPresent
Board Director AlveoGenePresent
Board Director HotmailPresent
Board of Directors Scripta TherapeuticsPresent
Board of Directors HotmailPresent
Partner Oxford Science EnterprisesPresent
Loughborough University MBA Business Administration and Management, General
Glasgow Caledonian University Ph.D Pharmacology
University of Glasgow BSc (Hons) Physiology